Clinical trial
Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia…
NCT00018642 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00018642 |
|---|---|
| Title | Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder |
| Official title | Predicting the Optimal Pharmacotherapy for Outpatients With Schizophrenia |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | quetiapine, haloperidol decanoate |
| Start date | Apr 1, 1997 |
| Completion | Mar 1, 2002 |
| First posted | Jul 5, 2001 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: